During the past decade, Clinica Vespucio conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Vespucio" #1 collaborator was "Clínica Vespucio, Santiago, Chile" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Vespucio" are "Bronchiolitis" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Influenza" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Respiratory Distress" (1 trials). Many other conditions were trialed in "Clinica Vespucio" in a lesser frequency.

Most popular intervention types in "Clinica Vespucio" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Placebo" (2 trials), "Baloxavir Marboxil" (1 trials), "Capecitabine" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Vespucio" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Vespucio". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinica Vespucio, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Vespucio, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".